- Electronic Arts (ERTS) to overweight from neutral at Piper Jaffray.
- Helix Energy (HLX) to overweight from equal weight at Morgan Stanley.
- Quest Software (QSFT) to neutral from sell at Goldman.
- LTX-Credence (LTXC) to buy from hold at Needham.
- Anadarko (APC) to buy from hold at Canaccord.
- Walgreen (WAG) to hold from sell at Citigroup.
- Pericom (PSEM) to buy from hold at ThinkEquity.
entr posts
FeedAnalyst Calls: APC, DLTR, ENR, ERTS, KKR, NUAN, QSFT, WAG, WWW ...
Continue reading Analyst Calls: APC, DLTR, ENR, ERTS, KKR, NUAN, QSFT, WAG, WWW ...
Analyst Calls: AAPL, ABFS, BIIB, EXC, HOG, PH, RIG, UTH, VITC ...
- Scotia Capital upgraded Apple (AAPL) to outperform from sector perform, citing valuation, potential increased iPhone distribution and iPad upside. The firm's two-year price target is $325.
- UBS upgraded Parker-Hannifin (PH) to neutral from sell following the company's better-than-expected Q3 report.
- Piper Jaffray upgraded Arkansas Best (ABFS) to neutral from underweight after the Teamsters union announced a tentative agreement with the company. The firm has a $33 price target for shares.
- Harley-Davidson (HOG) was upgraded to market perform from underperform at Raymond James.
- Allegheny Tech (ATI) was upgraded to buy from hold at KeyBanc.
- Manhattan Associates (MANH) was upgraded to buy from hold at Benchmark.
Continue reading Analyst Calls: AAPL, ABFS, BIIB, EXC, HOG, PH, RIG, UTH, VITC ...
Analyst upgrades, downgrades and initiations: AOL, CKR, DKS, GEF, MLM, TROW ...
- Stephens upgraded Martin Marietta (MLM) to overweight from equal weight on valuation and expectations that infrastructure and highway spending will increase. The firm raised its target on shares to $105 from $95.
- Janney Montgomery upgraded Shutterfly (SFLY) to buy from neutral to reflect valuation and a reduced pricing overhang after Kodak (EK) raised its 4x6 prices. The firm raised its target on shares to $21 from $18.
- Thomas Weisel upgraded Entropic Communications (ENTR) to overweight from market weight. The firm thinks the company is well-positioned for revenue growth in 2010, partly due to MoCA deployments from new customers and design wins for its silicon tuner product. The firm set a $5 target.
- T. Rowe Price (TROW) was upgraded to buy from hold at Jefferies.
- Dick's Sporting Goods (DKS) was upgraded to buy from neutral at BofA/Merrill.
- Massey Energy (MEE) was upgraded to overweight from neutral at JPMorgan.
Continue reading Analyst upgrades, downgrades and initiations: AOL, CKR, DKS, GEF, MLM, TROW ...
Analyst initiations: BMC, SMOD and ENTR
MOST NOTEWORTHY: BMC Software, Smart Modular and Entropic Comm were today's noteworthy initiations: - Stanford initiated BMC Software (NYSE: BMC) with a Buy rating and $45 target. The firm highlights the company's broad product portfolio and configuration management database leadership and thinks margin expansion should continue.
- ThinkPanmure assumed Smart Modular (NASDAQ: SMOD) with an Accumulate rating and $5.50 target. The firm expects better DRAM pricing but expects SMOD to experience some headwinds with Hewlett-Packard (HPQ) losing share in the server market.
- Broadpoint expects Entropic Comm (NASDAQ: ENTR) to benefit from the adoption of applications that allow video through numerous devices, especially high definition and data content. Shares were started with a Buy rating and $6 target.
- Banc of America initiated General Dynamics (NYSE: GD), Lockheed Martin (NYSE: LMT) and Northrop Grumman (NYSE: NOC) with Buy ratings and targets of $100, $120 and $80, respectively.
- Intercontinental Exchange (NYSE: ICE) was initiated with a Buy rating and $150 target at UBS.
- Intrepid Potash (NYSE: IPI) was assumed with a Buy rating at Merrill Lynch.
Analyst initiations: IBM, ENTR and FARO
MOST NOTEWORTHY: IBM, Entropic Comm and FARO Tech were today's noteworthy initiations:- BMO Capital is positive on IBM (NYSE: IBM) given the company's reduced pension and stock buyback, opportunity to increase the mix of software, new mainframe cycle, and the company's diverse revenue stream. Shares were initiated with an Outperform rating and $138 target.
- Merriman views Entropic Comm (NASDAQ: ENTR) as a core holding for investors seeking exposure to the rapidly growing home networking market and finds the current valuation attractive; the firm started shares with a Buy rating.
- Friedman Billings assumed FARO Tech (NASDAQ: FARO) with an Outperform rating and $42 target. The firm expects FARO's secular growth to drive sales as the company's products meet the needs of the largest emerging market for software-based manufacturing measurement systems.
Analyst initiations: NVDA, ENTR and CLF
MOST NOTEWORTHY: Nvidia, Entropic Comm and Cleveland Cliffs were today's noteworthy initiations:- Piper initiated Nvidia (NASDAQ: NVDA) with a Neutral rating and $23 target and believes the rate at which the company gained market share over the past two years is unsustainable. The firm expects EPS deceleration over the next few years.
- Piper believes Entropic Comm (NASDAQ: ENTR) is a key benefactor from the general adoption of high definition video consumer goods, as well as from growth in multi-room DVRs. The firm assumed shares with a Buy rating and $10 target.
- Cleveland Cliffs (NYSE: CLF) was started with a Buy rating and $135 target at Deutsche Bank. The firm believes CLF is a leveraged play on bulk commodities' momentum.
- Merrill initiated Allied Capital (NYSE: ALD) with a Neutral rating.
- Stifel initiated Blue Nile (NASDAQ: NILE) with a Buy rating and $54 target, and initiated Bank of Florida (NASDAQ: BOFL) with a Buy rating.
Analyst initiations: Entropic Comm, Epix Pharma, Hiland Partners
MOST NOTEWORTHY: Entropic Comm, Epix Pharma and Hiland Partners were today's noteworthy initiations:- JMP Securities is positive on Entropic's (NASDAQ: ENTR) business with Verizon (NYSE: VZ) Fios and Dish/Echostar (NASDAQ: DISH) and expects other high volume deployments to be announced with other cable service providers. The firm assumed coverage with a Strong Buy rating and $10 target.
- RBC Capital initiated Epix Pharma (NASDAQ: EPIX) with an Outperform rating and $6 target, as they are positive on the company's four programs targeting novel GPCR receptors, partnership deals with GlaxoSmithKline (NYSE: GSK) and Amgen (NASDAQ: AMGN), and low valuation.
- Morgan Keegan initiated Hiland Partners (NASDAQ: HLND) with an Outperform rating, as they view the company's units as undervalued.
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
Walmart's New Health Food Push: Is It Too Hard to Swallow?




